BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on ...
June 12, 2025
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.